CME Group Statistics
Total Valuation
CME Group has a market cap or net worth of $107.14 billion. The enterprise value is $106.35 billion.
| Market Cap | 107.14B |
| Enterprise Value | 106.35B |
Important Dates
The next confirmed earnings date is Wednesday, April 22, 2026, before market open.
| Earnings Date | Apr 22, 2026 |
| Ex-Dividend Date | Mar 10, 2026 |
Share Statistics
CME Group has 362.81 million shares outstanding. The number of shares has increased by 0.10% in one year.
| Current Share Class | 362.80M |
| Shares Outstanding | 362.81M |
| Shares Change (YoY) | +0.10% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 0.30% |
| Owned by Institutions (%) | 91.02% |
| Float | 361.18M |
Valuation Ratios
The trailing PE ratio is 26.46 and the forward PE ratio is 23.92. CME Group's PEG ratio is 3.02.
| PE Ratio | 26.46 |
| Forward PE | 23.92 |
| PS Ratio | 16.47 |
| Forward PS | 15.14 |
| PB Ratio | 3.69 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 25.55 |
| P/OCF Ratio | 25.05 |
| PEG Ratio | 3.02 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.17, with an EV/FCF ratio of 25.36.
| EV / Earnings | 26.45 |
| EV / Sales | 16.34 |
| EV / EBITDA | 23.17 |
| EV / EBIT | 24.97 |
| EV / FCF | 25.36 |
Financial Position
The company has a current ratio of 1.03, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.03 |
| Quick Ratio | 0.03 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.81 |
| Debt / FCF | 0.90 |
| Interest Coverage | 24.56 |
Financial Efficiency
Return on equity (ROE) is 14.75% and return on invested capital (ROIC) is 11.35%.
| Return on Equity (ROE) | 14.75% |
| Return on Assets (ROA) | 1.59% |
| Return on Invested Capital (ROIC) | 11.35% |
| Return on Capital Employed (ROCE) | 11.17% |
| Weighted Average Cost of Capital (WACC) | 5.80% |
| Revenue Per Employee | $1.68M |
| Profits Per Employee | $1.04M |
| Employee Count | 3,875 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CME Group has paid $1.26 billion in taxes.
| Income Tax | 1.26B |
| Effective Tax Rate | 23.61% |
Stock Price Statistics
The stock price has increased by +16.20% in the last 52 weeks. The beta is 0.30, so CME Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | +16.20% |
| 50-Day Moving Average | 305.78 |
| 200-Day Moving Average | 280.69 |
| Relative Strength Index (RSI) | 42.05 |
| Average Volume (20 Days) | 2,145,006 |
Short Selling Information
The latest short interest is 5.57 million, so 1.53% of the outstanding shares have been sold short.
| Short Interest | 5.57M |
| Short Previous Month | 4.95M |
| Short % of Shares Out | 1.53% |
| Short % of Float | 1.54% |
| Short Ratio (days to cover) | 2.43 |
Income Statement
In the last 12 months, CME Group had revenue of $6.51 billion and earned $4.02 billion in profits. Earnings per share was $11.16.
| Revenue | 6.51B |
| Gross Profit | 6.51B |
| Operating Income | 4.26B |
| Pretax Income | 5.33B |
| Net Income | 4.02B |
| EBITDA | 4.59B |
| EBIT | 4.26B |
| Earnings Per Share (EPS) | $11.16 |
Balance Sheet
The company has $4.54 billion in cash and $3.76 billion in debt, with a net cash position of $784.70 million or $2.16 per share.
| Cash & Cash Equivalents | 4.54B |
| Total Debt | 3.76B |
| Net Cash | 784.70M |
| Net Cash Per Share | $2.16 |
| Equity (Book Value) | 28.73B |
| Book Value Per Share | 80.03 |
| Working Capital | 5.06B |
Cash Flow
In the last 12 months, operating cash flow was $4.28 billion and capital expenditures -$83.50 million, giving a free cash flow of $4.19 billion.
| Operating Cash Flow | 4.28B |
| Capital Expenditures | -83.50M |
| Depreciation & Amortization | 330.90M |
| Net Borrowing | -9.40M |
| Free Cash Flow | 4.19B |
| FCF Per Share | $11.56 |
Margins
Gross margin is 100.00%, with operating and profit margins of 65.46% and 62.58%.
| Gross Margin | 100.00% |
| Operating Margin | 65.46% |
| Pretax Margin | 81.92% |
| Profit Margin | 62.58% |
| EBITDA Margin | 70.54% |
| EBIT Margin | 65.46% |
| FCF Margin | 64.45% |
Dividends & Yields
This stock pays an annual dividend of $11.35, which amounts to a dividend yield of 3.84%.
| Dividend Per Share | $11.35 |
| Dividend Yield | 3.84% |
| Dividend Growth (YoY) | 6.67% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 100.36% |
| Buyback Yield | -0.10% |
| Shareholder Yield | 3.74% |
| Earnings Yield | 3.75% |
| FCF Yield | 3.91% |
Analyst Forecast
The average price target for CME Group is $306.38, which is 3.75% higher than the current price. The consensus rating is "Buy".
| Price Target | $306.38 |
| Price Target Difference | 3.75% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 5.02% |
| EPS Growth Forecast (5Y) | 4.98% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 23, 2012. It was a forward split with a ratio of 5:1.
| Last Split Date | Jul 23, 2012 |
| Split Type | Forward |
| Split Ratio | 5:1 |
Scores
CME Group has an Altman Z-Score of 0.52 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.52 |
| Piotroski F-Score | 5 |